Thermo Fisher Scientific Inc. Financial Ratios — TMO AF

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	8.75	7.72	7.88	10.13	9.43	9.43	9.48	11.09	12.91	19.87	20.52	16.4	13.22	13.15	13.02
Return on Assets (%)	5.52	4.34	4.29	5.07	4.72	4.66	4.34	5.2	6.45	10.01	9.41	7.23	6.12	6.46	6.46
Return on Capital (%)	7.52	6.35	6.12	7.46	- -	- -	6.54	7.61	9.17	13.24	12.4	9.84	9.16	9.33	9.2
Return on Invested Capital (%)	6.16	6.96	6.57	5.54	- -	- -	6.63	7.44	8.1	13.47	13.57	10.05	8.73	8.62	8.65
Gross Margin (%)	41.47	42.33	42.24	44.36	45.72	45.81	45.17	44.57	44.35	49.67	50.08	42.24	39.9	41.28	40.93
EBITDA Margin (%)	19.09	20.37	20.53	21.25	24.4	24.11	24.33	25.04	25.28	31.72	32.69	26.47	25.02	25.25	24.44
Operating Margin (%)	11.66	12.5	12.89	11.28	14.45	14.49	14.61	15.74	16.37	24.5	26.08	18.94	17.08	18	18.2
Incremental Operating Margin (%)	8.49	22.81	21.21	5.72	725.73	14.9	15.51	22.56	29.39	55.6	33.35	-30.12	57.77	1,813.64	23.42
Pretax Margin (%)	9.8	10.15	10.08	12.36	11.41	11.08	11.61	13.39	15.94	22.44	22.55	17.44	14.7	16.41	16.4
Profit Margin (%)	11.51	9.42	9.73	11.22	11.64	11.06	10.64	12.06	14.47	19.79	19.7	15.47	13.99	14.77	15.05
Net Income to Common Margin (%)	11.51	9.42	9.73	11.22	11.64	11.06	10.64	12.06	14.47	19.79	19.7	15.47	13.99	14.77	15.05
Effective Tax Rate (%)	9.66	0.87	3.06	9.18	- -	- -	8.28	9.93	9.18	11.76	12.54	8.97	4.51	9.34	7.48
Dvd Payout Ratio (%)	- -	11.3	16.9	12.39	12.17	11.75	10.64	9.05	8.03	5.28	5.11	6.53	8.84	9.19	9.44
Sustainable Growth Rate (%)	8.75	6.85	6.55	8.87	8.28	8.32	8.47	10.08	11.87	18.82	19.47	15.33	12.05	11.94	11.79

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7,028	7,124	10,487	14,564	12,472	16,627	21,008	18,990	17,752	21,735	34,870	34,488	34,917	31,275	39,385
ST Debt	1,273	93	988	2,212	1,052	1,255	2,135	1,271	676	2,628	2,537	5,579	3,609	2,214	3,533
LT Debt	5,755	7,031	9,500	12,352	11,420	15,372	18,873	17,719	17,076	19,107	32,333	28,909	31,308	29,061	35,852
Total Debt/EBITDA	3.18	2.8	3.9	4.06	3.01	3.77	4.13	3.11	2.75	2.13	2.72	2.9	3.26	2.89	3.62
Net Debt/EBITDA	2.72	2.48	1.73	3.68	2.9	3.6	3.87	2.77	2.38	1.12	2.37	2.18	2.5	2.52	2.71
Total Debt/EBIT	5.22	4.55	6.22	7.65	5.09	6.28	6.87	4.95	4.25	2.75	3.41	4.05	4.77	4.05	4.86
Net Debt/EBIT	4.46	4.04	2.76	6.94	4.9	5.98	6.44	4.41	3.67	1.45	2.97	3.05	3.67	3.53	3.64
EBITDA to Interest Expense	12.59	10.55	10.25	7.48	9.98	9.39	8.6	9.15	9.55	18.48	23.91	16.37	7.8	7.79	7.67
EBITDA-CapEx/Interest Expense	11.1	9.24	9.18	6.59	8.96	8.45	7.74	8.01	8.18	15.81	19.21	13.29	6.72	6.78	6.6
EBIT to Interest Expense	7.69	6.47	6.44	3.97	5.91	5.64	5.16	5.75	6.18	14.27	19.08	11.72	5.32	5.55	5.72
Interest Expense	175	242	262	480	415	469	592	667	676	553	536	726	1,375	1,390	1,419
Common Equity/Total Assets	56.04	56.35	52.9	47.95	52.28	46.92	44.84	49.06	50.83	49.97	42.88	45.27	47.34	50.95	48.4
Long-Term Debt/Equity (%)	38.27	45.47	56.36	60.11	53.49	71.36	74.27	64.23	57.54	55.36	78.91	65.48	66.84	58.51	66.97
Long-Term Debt/Capital (%)	26.08	31.13	34.74	35.18	33.77	40.28	40.66	38.04	36	33.97	42.63	36.76	38.29	35.9	38.58
Long-Term Debt/Total Assets (%)	21.45	25.62	29.81	28.82	27.97	33.48	33.3	31.51	29.25	27.67	33.99	29.76	31.71	29.86	32.49
Total Debt/Equity (%)	46.73	46.07	62.22	70.88	58.42	77.19	82.67	68.84	59.82	62.97	85.1	78.12	74.54	62.96	73.57
Total Debt/Capital (%)	31.85	31.54	38.35	41.48	36.88	43.56	45.26	40.77	37.43	38.64	45.97	43.86	42.71	38.64	42.39
Total Debt/Total Assets (%)	26.19	25.96	32.91	33.99	30.54	36.22	37.07	33.77	30.41	31.48	36.66	35.5	35.37	32.14	35.69
Net Debt to Equity	39.98	40.86	27.65	64.34	56.3	73.54	77.41	61.22	51.74	33.06	74.17	58.81	57.3	54.89	55.16
Net Debt/Capital (%)	28.56	29.01	21.66	39.15	36.02	42.38	43.63	37.97	34.1	24.84	42.59	37.03	36.43	35.44	35.55
EBITDA	2,207	2,548	2,687	3,590	4,140	4,405	5,090	6,100	6,458	10,218	12,817	11,888	10,724	10,825	10,890
EBITDA-CapEx	1,946	2,233	2,405	3,162	3,717	3,961	4,582	5,342	5,532	8,744	10,294	9,645	9,245	9,425	9,365
Operating Income (Loss)	1,347	1,564	1,687	1,905	2,452	2,647	3,057	3,833	4,181	7,893	10,225	8,507	7,318	7,717	8,110

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.33	0.39	1.87	0.25	0.11	0.16	0.19	0.34	0.39	1	0.33	0.5	0.58	0.42	0.67
Current Ratio	1.55	2.31	3.16	1.22	1.38	1.44	1.34	1.73	1.92	2.13	1.5	1.48	1.75	1.66	1.89
Quick Ratio	0.89	1.25	2.49	0.72	0.78	0.87	0.74	1.09	1.19	1.63	1	1.06	1.27	1.14	1.36
CFO/Avg Current Liab	0.7	0.78	0.77	0.62	0.62	0.72	0.67	0.69	0.81	1	0.78	0.6	0.54	0.63	0.55
Common Equity/Total Assets	56.04	56.35	52.9	47.95	52.28	46.92	44.84	49.06	50.83	49.97	42.88	45.27	47.34	50.95	48.4
Long-Term Debt/Equity (%)	38.27	45.47	56.36	60.11	53.49	71.36	74.27	64.23	57.54	55.36	78.91	65.48	66.84	58.51	66.97
Long-Term Debt/Capital (%)	26.08	31.13	34.74	35.18	33.77	40.28	40.66	38.04	36	33.97	42.63	36.76	38.29	35.9	38.58
Long-Term Debt/Total Assets (%)	21.45	25.62	29.81	28.82	27.97	33.48	33.3	31.51	29.25	27.67	33.99	29.76	31.71	29.86	32.49
Total Debt/Equity (%)	46.73	46.07	62.22	70.88	58.42	77.19	82.67	68.84	59.82	62.97	85.1	78.12	74.54	62.96	73.57
Total Debt/Capital (%)	31.85	31.54	38.35	41.48	36.88	43.56	45.26	40.77	37.43	38.64	45.97	43.86	42.71	38.64	42.39
Total Debt/Total Assets (%)	26.19	25.96	32.91	33.99	30.54	36.22	37.07	33.77	30.41	31.48	36.66	35.5	35.37	32.14	35.69
CFO/Total Liabilities	14.34	17.02	13.4	11.74	15.1	13.37	12.81	15.86	17.32	24	17.2	17.27	16.2	18.19	13.76
CFO/CapEx	6.48	6.47	7.12	6.13	6.96	7.34	7.88	5.99	5.37	5.62	3.69	4.08	5.68	6.19	5.13
Altman's Z-Score	4.75	5.57	4.79	5.31	6.5	5.99	5.28	6.19	6.84	6.89	6.86	6.11	6.21	6.76	6.08

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.14	7.01	6.99	7.65	6.76	6.53	6.04	6.08	6.02	6.39	5.72	5.58	5.25	5.23	5.21
Days Sales Outstanding	51.12	52.06	52.24	47.72	53.99	55.87	60.44	60.05	60.63	57.16	63.85	65.39	69.56	69.85	70
Inventory Turnover	5.41	5.2	5.15	5.6	4.78	4.71	4.43	4.52	4.46	4.38	4.31	4.86	4.8	5	5.06
Days Inventory Outstanding	67.53	70.16	70.91	65.13	76.32	77.5	82.48	80.78	81.85	83.28	84.66	75.16	75.97	72.97	72.14
Accounts Payable Turnover	11.94	11.69	11.42	12.91	11.37	11.58	10.39	8.9	8.25	8.24	8.17	8.49	8.06	8.42	7.99
Accounts Payable Turnover Days	30.56	31.22	31.96	28.27	32.1	31.52	35.13	41.03	44.25	44.29	44.68	42.98	45.26	43.33	45.69
Cash Conversion Cycle	88.08	90.99	91.19	84.58	98.21	101.84	107.79	99.8	98.23	96.14	103.83	97.56	100.27	99.49	96.45
Inventory to Cash Days	-16.41	-18.1	-18.67	-17.42	-22.34	-21.63	-22.04	-20.73	-21.23	-26.13	-20.81	-9.78	-6.41	-3.11	-2.14
Inventories	1,330	1,443	1,494	1,860	1,992	2,213	2,971	3,005	3,370	4,029	5,051	5,634	5,088	4,978	5,425
Raw Materials	335	362	347	442	421	466	708	812	971	1,305	1,922	2,405	2,057	1,803	1,877
Work In Process	129	150	158	208	237	328	505	430	517	540	676	660	705	755	889
Finished Goods	866	932	989	1,210	1,334	1,419	1,758	1,763	1,882	2,184	2,453	2,569	2,326	2,420	2,659
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	16,701	22,798	40,304	50,175	56,688	55,515	76,202	89,991	129,539	184,761	263,183	215,050	205,229	198,090	218,002
- Cash & Cash Equivalents	1,016	806	5,826	1,344	452	786	1,335	2,103	2,399	10,325	4,477	8,524	8,077	4,009	9,852
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	10	184	170	107	87	129
+ Total Debt	7,028	7,124	10,487	14,564	12,472	16,627	21,008	18,990	17,752	21,735	34,870	34,488	34,917	31,275	39,385
Enterprise Value	22,708	29,112	44,961	63,387	68,707	71,356	95,875	106,878	144,892	196,181	293,760	241,184	232,173	223,882	247,411
Total Capital	22,066	22,589	27,343	35,112	33,822	38,167	46,421	46,576	47,427	56,252	75,847	78,636	81,759	80,947	92,921
Total Debt/Capital (%)	31.85	31.54	38.35	41.48	36.88	43.56	45.26	40.77	37.43	38.64	45.97	43.86	42.71	38.64	42.39
Total Debt / EV	0.31	0.24	0.23	0.23	0.18	0.23	0.22	0.18	0.12	0.11	0.12	0.14	0.15	0.14	0.16
EV/Sales	1.96	2.33	3.43	3.75	4.05	3.9	4.58	4.39	5.67	6.09	7.49	5.37	5.42	5.22	5.55
EV/EBITDA	10.29	11.43	16.73	17.66	16.6	16.2	18.84	17.52	22.44	19.2	22.92	20.29	21.65	20.68	22.72
EV/EBIT	16.85	18.61	26.65	33.28	28.02	26.96	31.36	27.88	34.65	24.86	28.73	28.35	31.73	29.01	30.51
EV/Cash Flow to Firm	12.28	12.77	19.85	20.75	20.41	19.14	21.08	20.78	25.93	22.35	30.03	24.57	23.89	22.55	27.1
EV/Free Cash Flow to Firm	10.76	11.22	17.65	18.2	18.13	17.11	18.96	18.11	22.25	19.14	23.88	20	20.73	19.76	23.22
Diluted Market Cap	17,304	23,382	40,732	50,404	57,010	56,073	75,572	90,859	130,923	185,846	264,894	216,972	205,947	199,248	219,032
Diluted Enterprise Value	23,316	29,700	45,393	63,625	69,029	71,914	95,245	107,746	146,276	197,266	295,471	243,106	232,894	226,601	248,694
EV per Share	61.15	81.45	124.22	158.28	171.93	181.36	238.9	265.78	363.37	494.57	744.76	617.61	600.48	587.97	657.62
TTM Sales	11,559	12,510	13,090	16,890	16,965	18,274	20,918	24,358	25,542	32,218	39,211	44,915	42,857	42,879	44,557
TTM EBITDA	2,207	2,548	2,687	3,590	4,140	4,405	5,090	6,100	6,458	10,218	12,817	11,888	10,724	10,825	10,890
TTM Operating Income	1,347	1,564	1,687	1,905	2,452	2,647	3,057	3,833	4,181	7,893	10,225	8,507	7,318	7,717	8,110
TTM Cash Flow to Firm	1,849	2,279	2,265	3,055	3,366	3,727	4,548	5,144	5,587	8,777	9,781	9,815	9,719	9,927	9,131
TTM Free Cash Flow to Firm	2,110	2,594	2,547	3,483	3,789	4,171	5,056	5,902	6,513	10,251	12,304	12,058	11,198	11,327	10,656

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	8.87	9.93	17.76	16.54	16.94	15.15	16.75	17.14	22.19	19.04	22.38	19.04	20.83	19.79	23.44
EV/EBIT	16.85	18.61	26.65	33.28	28.02	26.96	31.36	27.88	34.65	24.86	28.73	28.35	31.73	29.01	30.51
Enterprise Value	22,708	29,112	44,961	63,387	68,707	71,356	95,875	106,878	144,892	196,181	293,760	241,184	232,173	223,882	247,411
Low Price	43.06	45.67	64.54	107.33	117.1	119.75	140	190.38	210.07	250.21	433.52	475.77	415.6	493.3	385.46
EV/Sales	1.96	2.33	3.43	3.75	4.05	3.9	4.58	4.39	5.67	6.09	7.49	5.37	5.42	5.22	5.55
EV/EBITDA	10.29	11.43	16.73	17.66	16.6	16.2	18.84	17.52	22.44	19.2	22.92	20.29	21.65	20.68	22.72
Price/Earnings	12.88	19.7	31.51	26.34	28.64	27.55	33.71	30.62	35.16	28.93	34.03	31.06	34.18	31.37	32.59
Price/Earnings Average	15.83	17.36	24.53	25.22	26.4	28.49	30.79	30.34	30.18	23.84	27.11	31.22	34.12	34.31	27.98
Price/Earnings High	18.86	20.24	31.53	27.28	29	31.37	35.72	34.74	35.73	33.08	34.29	37.47	39.27	37.86	34.36
Price/Earnings Low	12.33	14.11	18.26	22.56	23.64	23.38	24.85	26.05	22.73	15.54	22.11	26.83	26.76	29.75	21.68
Price/Book Value	1.11	1.47	2.39	2.44	2.66	2.58	3	3.26	4.37	5.35	6.45	4.89	4.39	3.99	4.08
Price/Book Value Average	1.37	1.3	1.86	2.34	2.45	2.67	2.74	3.23	3.75	4.41	5.14	4.92	4.38	4.37	3.51
Price/Book Value High	1.63	1.51	2.39	2.53	2.69	2.93	3.18	3.7	4.44	6.12	6.5	5.9	5.05	4.82	4.3
Price/Book Value Low	1.06	1.06	1.39	2.09	2.19	2.19	2.21	2.78	2.82	2.88	4.19	4.22	3.44	3.79	2.72
Price/Tangible Book Value	-3.52	-4.74	-14.83	-4.04	-5.54	-4.04	-4.6	-7.06	-12.89	-43.79	-12.39	-14.67	-14.71	-16.79	-18.49
Price/Tangible Book Value Average	-4.32	-4.17	-11.54	-3.87	-5.11	-4.17	-4.2	-7	-11.06	-36.09	-9.87	-14.75	-14.68	-18.36	-15.87
Price/Tangible Book Value High	-5.15	-4.87	-14.84	-4.19	-5.61	-4.6	-4.88	-8.01	-13.09	-50.07	-12.48	-17.69	-16.9	-20.26	-19.49
Price/Tangible Book Value Low	-3.37	-3.39	-8.59	-3.47	-4.57	-3.42	-3.39	-6.01	-8.33	-23.52	-8.05	-12.67	-11.51	-15.92	-12.3
Price/Sales	1.48	1.85	3.06	2.95	3.33	3.05	3.59	3.69	5.09	5.73	6.7	4.81	4.78	4.63	4.9
Price/Sales Average	1.82	1.63	2.39	2.83	3.07	3.15	3.28	3.66	4.37	4.72	5.34	4.83	4.77	5.07	4.21
Price/Sales High	2.17	1.91	3.07	3.06	3.38	3.47	3.8	4.19	5.17	6.55	6.76	5.8	5.49	5.59	5.17
Price/Sales Low	1.42	1.33	1.78	2.53	2.75	2.59	2.64	3.14	3.29	3.08	4.36	4.15	3.74	4.39	3.26
Price/Cash Flow	10.13	11.38	19.95	19.05	19.22	17.1	18.73	19.8	26.13	22.25	28.23	23.58	24.37	22.93	27.94
Price/Cash Flow Average	12.45	10.02	15.53	18.24	17.72	17.68	17.11	19.62	22.43	18.34	22.49	23.7	24.33	25.08	24
Price/Cash Flow High	14.83	11.69	19.97	19.73	19.47	19.47	19.84	22.47	26.55	25.44	28.45	28.45	28	27.67	29.46
Price/Cash Flow Low	9.7	8.15	11.57	16.32	15.87	14.51	13.81	16.85	16.9	11.95	18.34	20.37	19.08	21.74	18.59
Price/Free Cash Flow Average	10.9	8.75	13.83	15.84	15.62	15.66	15.3	16.98	19.05	15.69	17.83	19.14	20.8	21.65	20.13
Price/Free Cash Flow High	12.98	10.2	17.78	17.13	17.16	17.25	17.74	19.45	22.55	21.77	22.55	22.96	23.94	23.89	24.72
Price/Free Cash Flow Low	8.49	7.11	10.3	14.17	13.99	12.85	12.35	14.58	14.35	10.23	14.54	16.45	16.31	18.77	15.59
EV/Sales Average	2.3	2.11	2.75	3.63	3.79	4.01	4.27	4.35	4.95	5.08	6.13	5.39	5.41	5.69	4.87
EV/Sales High	2.64	2.38	3.44	3.86	4.09	4.33	4.8	4.89	5.75	6.91	7.54	6.36	6.13	6.21	5.82
EV/Sales Low	1.9	1.81	2.14	3.33	3.47	3.45	3.63	3.84	3.88	3.44	5.14	4.72	4.38	5.02	3.92
EV/EBITDA Average	12.03	10.36	13.41	17.07	15.53	16.63	17.54	17.39	19.59	16.02	18.74	20.38	21.62	22.54	19.91
EV/EBITDA High	13.81	11.67	16.75	18.16	16.77	17.95	19.73	19.51	22.76	21.79	23.08	24.02	24.5	24.61	23.83
EV/EBITDA Low	9.97	8.89	10.43	15.66	14.21	14.29	14.9	15.32	15.35	10.83	15.73	17.83	17.5	19.88	16.04
EV/EBIT Average	19.7	16.88	21.36	32.16	26.21	27.67	29.21	27.67	30.26	20.74	23.49	28.48	31.68	31.62	26.74
EV/EBIT High	22.62	19.02	26.67	34.22	28.31	29.87	32.85	31.04	35.16	28.21	28.93	33.57	35.9	34.53	32
EV/EBIT Low	16.33	14.48	16.61	29.51	23.99	23.78	24.81	24.38	23.71	14.02	19.71	24.91	25.64	27.89	21.54
Last Price	44.97	63.78	111.35	125.29	141.85	141.1	189.88	223.79	324.87	465.78	667.24	550.69	530.79	520.23	579.45
High Price	65.86	65.54	111.44	129.77	143.65	160.68	201.2	253.91	330.14	532.57	672.34	664.27	609.85	627.88	610.97
Enterprise Value Average	26,539	26,406	36,041	61,262	64,275	73,252	89,283	106,064	126,534	163,685	240,200	242,302	231,819	244,022	216,870
Enterprise Value High	30,471	29,746	44,998	65,189	69,427	79,060	100,417	118,990	146,993	222,675	295,771	285,539	262,744	266,434	259,522
Enterprise Value Low	22,003	22,643	28,022	56,203	58,817	62,956	75,857	93,443	99,116	110,671	201,572	211,927	187,638	215,189	174,680

Shares Outstanding	371	357	362	400	400	393	401	402	399	397	394	391	387	381	376
Diluted Weighted Avg Shares	385	367	366	402	402	397	398	406	403	399	397	394	388	383	378
Basic Weighted Avg Shares	381	364	360	398	399	395	395	402	400	396	394	392	386	382	377
Revenue per Share	30.35	34.39	36.33	42.41	42.55	46.29	52.96	60.59	63.86	81.36	99.52	114.58	111.03	112.25	118.19
EBITDA per Share	5.8	7	7.46	9.01	10.38	11.16	12.89	15.17	16.14	25.8	32.53	30.33	27.78	28.34	28.89
Operating Income per Share	3.54	4.3	4.68	4.78	6.15	6.7	7.74	9.53	10.45	19.93	25.95	21.7	18.96	20.2	21.51
Basic EPS, GAAP	3.49	3.24	3.53	4.76	4.95	5.12	5.63	7.31	9.24	16.1	19.61	17.73	15.53	16.58	17.78
Basic EPS from Cont Ops	2.69	3.46	3.55	4.76	4.97	5.13	5.64	7.31	9.24	16.1	19.61	17.76	15.43	16.59	17.83
Diluted EPS, GAAP	3.46	3.21	3.48	4.71	4.91	5.09	5.59	7.24	9.17	15.98	19.46	17.64	15.45	16.54	17.74
Diluted EPS from Cont Ops	2.66	3.43	3.5	4.71	4.93	5.1	5.6	7.24	9.18	15.98	19.47	17.66	15.35	16.55	17.78
Dividend per Share	- -	0.39	0.6	0.59	0.6	0.6	0.6	0.66	0.74	0.85	1	1.16	1.35	1.53	1.69
Cash Flow per Share	4.44	5.61	5.58	6.58	7.38	8.25	10.14	11.3	12.43	20.93	23.63	23.35	21.78	22.69	20.74
Free Cash Flow per Basic Share	3.76	4.74	4.8	5.5	6.32	7.13	8.85	9.42	10.12	17.21	17.23	17.63	17.95	19.02	16.69
Cash & Equivalents per Share	2.75	2.27	16.11	3.38	1.13	2	3.33	5.23	6.02	26.03	11.35	21.83	20.9	14.63	26.86
Book Value per Share	40.49	43.26	46.57	51.31	53.42	54.75	63.32	68.6	74.42	86.99	103.42	112.62	120.87	130.22	141.96
Tangible Book Value per Share	-12.79	-13.47	-7.51	-30.98	-25.61	-34.97	-41.27	-31.68	-25.21	-10.64	-53.86	-37.54	-36.09	-30.99	-31.35

Thermo Fisher Scientific Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)